Literature DB >> 15711954

Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.

Jelena Roganovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15711954     DOI： 10.1007/s00431-005-1631-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?

Authors:  Giovanna Russo; Maria Licciardello; Milena La Spina
Journal:  Eur J Pediatr       Date:  2004-07-08       Impact factor: 3.183

2.  Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.

Authors:  Anna Pusiol; Simone Cesaro; Agostino Nocerino; Giorgio Picco; Luigi Zanesco; Gianni Bisogno
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

Review 3.  Management of immune thrombocytopenic purpura in adults.

Authors:  Roberto Stasi; Drew Provan
Journal:  Mayo Clin Proc       Date:  2004-04       Impact factor: 7.616
  3 in total
  2 in total

Review 1.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

Review 2.  Treatment of immune thrombocytopenic purpura in children : current concepts.

Authors:  Aziza T Shad; Corina E Gonzalez; S G Sandler
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.